EverlyWell Stock
At-Home Lab Testing
Sign up today and learn more about EverlyWell Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About EverlyWell Stock
EverlyWell develops do-it-yourself kits for a vast range of at-home regulatory-compliant diagnostic tests including food sensitivity, fertility, hormones, STDs, thyroid, and metabolism among the others, allowing users to perform tests at home and receive physician-reviewed results and insights on their mobile devices.
Investors
BlackRock
Databricks, Rivian, Relativity Space, View, Carbon Health, Scopely, Snyk, Jawbone, MessageBird, DataRobot
The Chernin Group
Scopely, OpenSea, EverlyWell, Medium, Cameo, Zola, The Athletic, Lovevery, Parsley Health, Barstool Sports
Next Coast Ventures
Techammer
DataRobot, Cityblock Health, EverlyWell, Emulate, Imperfect Foods, Pymetrics
SoGal Ventures
Funding History
| February 2016 | $3.1M |
|---|---|
| December 2017 | $2.4M |
| December 2017 | $10.3M |
| February 2019 | $30.0M |
| February 2020 | $25.0M |
| November 2020 | $258M |
Management
Chief Executive Officer
Julia Cheek
Chief Financial Officer
Chris Bishko
Chief Technology Officer
Nick Parker
Press
fiercepharma - Apr, 8 2024
Everlywell fights 'stool stigma' to promote colon cancer testingartrocker - Feb, 24 2024
COVID-19 Nucleic Acid Testing Kits Market Growing Massively by-Roche, Cosara Diagnostics, Everlywell, Seegene ...techiegamers - Jan, 30 2024
Everlywell Net Worth - it's Become a Billion-Dollar Business Since Shark Tank!healthdigest - Dec, 22 2023
Where Is EverlyWell From Shark Tank Season 9 Today?nasdaq - Dec, 22 2023
Five Stocks That Tap Into the Exploding Market for At-Home ...EquityZen Recognized As:
